The benefit-risk balance of thiomersal-containing vaccines remains overwhelmingly positive

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1376, 2003-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

When science is not enough – a risk/benefit profile of thiomersal-containing vaccines

By Clements C John   McIntyre Peter B  

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 17-29

Informa Healthcare

Access to resources Recommend Favorite

EMEA supports safety of thiomersal-containing vaccines

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Benefit-risk balance of birth-control pills affirmed

By  

Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Thiomersal in Vaccines: Balancing the Risk of Adverse Effects with the Risk of Vaccine-Preventable Disease

By Mark Bigham   Ray Copes  

Drug Safety, Vol. 28, Iss. 2, 2005-01 ,pp. : 89-101

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

By Falagas Matthew E.   Vardakas Konstantinos Z.  

Drug Safety, Vol. 31, Iss. 9, 2008-01 ,pp. : 753-768

Adis International

Access to resources Recommend Favorite